en POLSKI
eISSN: 2084-9834
ISSN: 0034-6233
Reumatologia/Rheumatology
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank


1/2008
vol. 46
 
Share:
Share:
abstract:

Review article
Macrophage activation syndrome – a reactive haemophagocytic lymphohistiocytosis

Aleksandra Zoń-Giebel
,
Sebastian Giebel

Reumatologia 2008; 46, 1: 21–26
Online publish date: 2008/02/28
View full text Get citation
 
Macrophage activating syndrome (MAS) being a reactive form of haemophagocytic lymphohistiocytosis (HLH) is increasingly diagnosed complication of rheumatic diseases including juvenile idiopathic arthritis, adult-onset Still’s disease, and systemic lupus erythematosus. Both MAS and familial HLH are associated with impaired activity of NK cells resulting in increased activation and proliferation of macrophages with excessive cytokine production and organ infiltration. Typical symptoms include fever, organomegaly, and cytopenia being a consequence of haemophagocytosis. Increased ferritin level, hypofibrinogenemia, and hypertriglyceridemia are useful laboratory markers. The management comprise elimination of the triggering factor, i.e. usually viral infection, high-dose glucocorticosteroids, cyclosporine A, intravenous immunoglobulins, and etoposide.
keywords:

macrophage activation syndrome, haemophagocytic lymphohistiocytosis




Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.